Sequencing Updates from Agilent Technologies
Abstract
Agilent Technologies is committed to continued innovation of sequencing reagents, workflows, and data analysis solutions, both for the committed researcher as well as the clinician working towards improved human health and... [ view full abstract ]
Agilent Technologies is committed to continued innovation of sequencing reagents, workflows, and data analysis solutions, both for the committed researcher as well as the clinician working towards improved human health and treatment options. Our products aim to help solve challenges faced in the laboratory today – from basic workflow improvements to improving detection sensitivity for lowly expressed transcripts and alternate alleles. As long-time leaders in the microarray industry, we also understand the importance of accurate detection of copy number changes across samples, and we have new technologies that transfer this capability from arrays to NGS, with improved detection over standard NGS applications for CNV calling. For better detection of disease-associated regions with exome sequencing, we have launched a new version of the Clinical Research Exome, which improves depth of coverage in the disease-associated regions that matter most to clinicians, as well as adds coverage for pathogenic/likely pathogenic variants that are otherwise often missed in basic exome designs. When the NGS analysis is complete, you can now use our custom CRISPR libraries to enable downstream functional assays. And finally, to assist with both analysis and interpretation of the vast amounts of NGS data these tests generate, we have launched a cloud-based software solution, Agilent Alissa, which can be fine-tuned for analysis and streamlined variant interpretation. Whether you are looking for a complete package of target enrichment, workflow, and analysis, or need a specific customized component to build into your existing lab infrastructure, Agilent Technologies can provide each piece along the way of your sequencing journey. Join our tech talk to learn more about how these technology innovations can make an impact on your research goals.
Authors
-
Kristi Stephenson
(Agilent Technologies)
Topic Areas
De novo sequencing, re-sequencing, Human seq., RNA seq., metagenomics, etc. , Comparative genomics, re-sequencing, SNPs, structural variation , Bringing sequence to the clinic (i.e., diagnostics, cancer, inherited disorders)
Session
TT-2 » Sample Preparation & Sequencing (15:50 - Tuesday, 16th May, La Fonda Ballroom)
Presentation Files
The presenter has not uploaded any presentation files.